Keywords:
Biological effects, Athletic injuries, Diagnostic procedure, Decision analysis, Computer Applications-Detection, diagnosis, Ultrasound, MR, CT-Quantitative, Musculoskeletal system, Musculoskeletal soft tissue, Extremities, Inflammation
Authors:
D. Dalili, T. M. Bansal, A. Isaac; London/UK
DOI:
10.1594/essr2018/P-0162
References
1. Furst DE,
Amato AA,
Iorga SR,
Gajria K,
Fernandes AW.
Epidemiology of adult idiopathic inflammatory myopathies in a U.S.
managed care plan. Muscle Nerve. 2012;45:676–683.
2. Martin N,
Li CK,
Wedderburn LR.
Juvenile dermatomyositis: new insights and new treatment strategies. Ther Adv Musculoskelet Dis. 2012;4:41–50.
3. Salajegheh M,
Kong SK,
Pinkus JL,
et al.
Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy. Ann Neurol. 2010;67:53–63.
4.
Walczak BE,
Johnson CN,
Howe BM. Myositis ossificans.
J Am Acad Orthop Surg. 2015; 23: 612– 622.
5. Lilleker JB,
Vencovsky J,
Wang G,
et al.
The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Annals of the Rheumatic Diseases.
2018;77(1):30-39.
6. Tansley SL,
Simou S,
Shaddick G,
et al.
Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort. Journal of Autoimmunity.
2017;84:55-64.
7. Burlina P,
Billings S,
Joshi N,
Albayda J.
Automated diagnosis of myositis from muscle ultrasound: Exploring the use of machine learning and deep learning methods.
Miller FW,
ed. PLoS ONE.
2017;12(8):e0184059.